Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. - Wikidata - awgldk - TriplyDB

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

http://www.wikidata.org/entity/Q42153590

about

Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading Biomaterials for hollow organ tissue engineering Bone Regeneration from PLGA Micro-Nanoparticles Biomaterial Approaches to Enhancing Neurorestoration after Spinal Cord Injury: Strategies for Overcoming Inherent Biological Obstacles Drug Carrier for Photodynamic Cancer Therapy Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering Nanotechnology-based drug delivery systems for treatment of oral cancer: a review Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applications Targeted therapy using nanotechnology: focus on cancer Periadventitial application of rapamycin-loaded nanoparticles produces sustained inhibition of vascular restenosis Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles.Polydopamine-Assisted Surface Modification for Bone Biosubstitutes Advancements in the delivery of epigenetic drugs Externally controlled triggered-release of drug from PLGA micro and nanoparticles New Perspective in the Formulation and Characterization of Didodecyldimethylammonium Bromide (DMAB) Stabilized Poly(Lactic-co-Glycolic Acid) (PLGA) Nanoparticles Enhancing Macrophage Drug Delivery Efficiency via Co-Localization of Cells and Drug-Loaded Microcarriers in 3D Resonant Ultrasound Field.Anthracycline Drugs on Modified Surface of Quercetin-Loaded Polymer Nanoparticles: A Dual Drug Delivery Model for Cancer Treatment Manufacturing of a Secretoneurin Drug Delivery System with Self-Assembled Protamine Nanoparticles by Titration Microfluidic Production of Biodegradable Microcapsules for Sustained Release of Hydrophilic Actives.Enhanced osseous integration of human trabecular allografts following surface modification with bioactive lipids.Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.Near-infrared-induced heating of confined water in polymeric particles for efficient payload release.Heuristic modeling of macromolecule release from PLGA microspheres.Collective activation of MRI agents via encapsulation and disease-triggered release Sustained Release of Protein Therapeutics from Subcutaneous Thermosensitive Biocompatible and Biodegradable Pentablock Copolymers (PTSgels)Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line.A review of the applications of data mining and machine learning for the prediction of biomedical properties of nanoparticles.In vitro stress effect on degradation and drug release behaviors of basic fibroblast growth factor--poly(lactic-co-glycolic-acid) microsphere.Fabrication, characterization, and biological evaluation of anti-HER2 indocyanine green-doxorubicin-encapsulated PEG-b-PLGA copolymeric nanoparticles for targeted photochemotherapy of breast cancer cells Surface modification of PdlLGA microspheres with gelatine methacrylate: Evaluation of adsorption, entrapment, and oxygen plasma treatment approaches.Effects of 3D-Printed Polycaprolactone/β-Tricalcium Phosphate Membranes on Guided Bone Regeneration Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection.Injectable scaffold materials differ in their cell instructive effects on primary human myoblasts Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.Nano-palladium is a cellular catalyst for in vivo chemistry Development of therapeutic polymeric nanoparticles for the resolution of inflammation.Biomaterials for nanoparticle vaccine delivery systems.Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?Biodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs.

P2860

Q26738335-7368C767-7DF5-42DF-9AC2-446EC0404F8E Q26750949-D00198F6-BD82-4472-AAC2-B214C6D9FA76 Q26778233-6C9A25D2-80C3-437D-AD2A-FFAED3DA9ED7 Q26780494-787679C8-115E-478E-9B15-10047B119E17 Q26782780-09DEB249-FA9C-4EB2-BF64-1635E29B41A5 Q26799856-F2361605-71DF-4005-B683-1F05057A62B6 Q26824180-0C1A7348-CC9C-4A68-A727-47C89FA34122 Q26995835-7EF63A34-CF62-4941-A728-68F7019B5A0B Q27012561-5D33A2C7-05FE-412E-9664-8CBEB2A56CEF Q27023361-7EBDED55-CF31-4D72-976E-362D6EE57AEF Q27321271-503144C5-2AB8-4D00-ADF8-B814B0A49657 Q27333474-C9274145-7199-451B-9389-1C676655244D Q28070293-22B71BD6-A91D-4694-B4AD-8CB927E6E3E0 Q28088478-A811ED96-008C-419F-B349-019A6F219E8F Q28542537-ACE94B67-9EED-4415-8CA7-EDA6AB36AD1A Q28546279-0D4264EC-784C-4049-AD75-B64A65C3C147 Q28547168-90410AEA-2D7E-4EF5-87DE-29C09107AA65 Q28552231-58BB3930-276F-469C-A41A-CC0F1E2E629E Q28553301-2DAD14E9-646F-4A18-B7B2-930C9116B64D Q30101067-C274D83C-6F3E-4245-ABD8-F05277C3BE95 Q30279024-E022D554-AC78-4B6E-9BDA-6FBD45273032 Q30385768-42DD0F13-734C-4CD9-8721-F864453F83F1 Q30415679-E72EE8DC-E35E-4987-ACCC-9E14C4289910 Q30559113-6EDC756F-1267-48BC-9842-9C0CFC853671 Q30625860-09CAD0F9-2916-4C23-9BC2-A8800D5E1909 Q30824011-D7771368-F1C1-42BF-ABF9-7AD1DA064A3C Q30978874-5D99AFD4-7787-4D6A-A227-D4AA068A28DC Q31106864-809C03A4-A597-4303-9606-6F05AFD65FAE Q33467199-D2424E1C-908F-4C63-8507-84DE9AF30CDA Q33587331-277690C5-03CE-4E4A-8415-13653C172BEF Q33656519-1FC34A92-48EF-4642-A629-60239B6C8984 Q33754740-A5C8FB6D-1AB5-47CD-9482-9FFD300B3F98 Q33799315-30DFDF2D-E242-4357-93E6-A71DFDDBE8D2 Q33887599-B806F834-7E77-4094-B434-9E61E81870F5 Q33902253-FD9DED9F-5382-48CA-B2AA-38B5443BEE50 Q33903811-95417333-7A53-485B-A838-118277412470 Q34160852-AAB9B161-9023-4689-84AB-3A316D8FC97C Q34345012-6E0511F3-377D-475B-829A-A518A50706EB Q34383339-BC283DB6-A3E5-4787-9551-230D5F26BE90 Q34464430-0B67F9AB-A13A-4410-BF86-C2BD0F0F6010

P2860

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

http://www.wikidata.org/entity/Q42153590

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

@en

Poly Lactic-co-Glycolic Acid

@nl

type

label

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

@en

Poly Lactic-co-Glycolic Acid

@nl

prefLabel

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

@en

Poly Lactic-co-Glycolic Acid

@nl

P1433

Q42153590-24FEE85F-AB99-4970-85BF-3E99479A6E0D

P1476

Q42153590-EE9A7815-2376-43F4-9BAE-A40A51BEA457

P2860

Q42153590-02BEBE63-039B-4A97-B106-16F6BD189AC5

Q42153590-0580089E-D535-4C16-AFC1-0B9E6A07E38D

Q42153590-0964C8F0-A7C1-4C9B-854D-5F9F270E9B5C

Q42153590-0BFD9AC2-F349-4838-BB0B-07C1947D2976

Q42153590-0F703F5C-B612-4A24-92A0-02A336F42A33

Q42153590-16B7E702-4BBC-4991-A259-BB90FBE5BB4C

Q42153590-1C7A1B47-74AA-457E-9C00-31A06DA52594

Q42153590-1E06691D-F8FC-4A36-9501-DC7E9B222A50

Q42153590-1ED70249-4954-4239-9993-94C6FAEDBEE9

Q42153590-257800EE-FA7D-44C8-B332-6982B94592B0

P304

Q42153590-42CC9B50-24FA-4EC6-9A73-F980E33FECDF

P31

Q42153590-C67F5EA6-3937-4E5A-9652-FB44442D32D5

P356

Q42153590-DFA629F0-207A-4512-92DC-1D30AE6B8D69

P433

Q42153590-AF073A43-0D35-4EEB-8D89-1298BE3C4F23

P478

Q42153590-2453FDEE-AD99-4601-BA62-EF0DE916BF09

P50

Q42153590-483EE378-CADC-4788-AAA4-5302F33BF227

Q42153590-BD78BBBB-FEE2-4B55-8C57-2309962A507C

P577

Q42153590-6C937179-5DFB-4A63-8E88-C7E6550024C5

P5875

Q42153590-C6F16EC3-FA2E-4739-BEB4-E8682C86CFAA

P698

Q42153590-7950DED9-F9B3-42A1-80B4-065D8A9743B5

P921

Q42153590-46598BB7-9722-4495-B7C3-A4FF5B7A7C9B

Q42153590-ABF5D71A-987D-4CAE-8E5A-8127886F14E1

P932

Q42153590-9EED3B8D-D520-47BF-93B5-90F49451E655

P356

P1433

P1476

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

@en

P2860

Effect of drug type on the degradation rate of PLGA matrices

Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material

In vitro and in vivo demonstration of risperidone implants in mice.

Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.

In vitro degradation and controlled release behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 copolymer microspheres.

Microparticle formation and its mechanism in single and double emulsion solvent evaporation.

Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.

Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.

Biodegradation and biocompatibility of PLA and PLGA microspheres.

The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.

P304

1377-1397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/POLYM3031377

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Steven J. Siegel

Hirenkumar K Makadia

P577

2011-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224940672

http://www.w3.org/2001/XMLSchema#string

P698

22577513

http://www.w3.org/2001/XMLSchema#string

P921

P932

3347861

http://www.w3.org/2001/XMLSchema#string